Antidepressant Fluvoxamine in Reducing COVID-19 Hospitalization

Authors

  • Saad Shakil Ziauddin Medical College
  • Sareema Eman Akhtar Ziauddin Medical College
  • Akhtar Ali Ziauddin Medical College

DOI:

https://doi.org/10.36283/PJMD11-2/015

Abstract

Dear Editor,

In this era of the 21st century, when a global pandemic has taken over the lives of millions, causing severe hospitalization and even death, the need for treatment has become an ongoing challenge despite the relative progress made by vaccination.

Downloads

Published

2023-11-20

How to Cite

Shakil, S., Akhtar, S. E., & Ali, A. (2023). Antidepressant Fluvoxamine in Reducing COVID-19 Hospitalization. Pakistan Journal of Medicine and Dentistry, 11(2), 95–96. https://doi.org/10.36283/PJMD11-2/015

Issue

Vol. 11 No. 2 (2022): Vol. 11 No. 2(2022): Pakistan Journal of Medicine and Dentistry, 11-2, April - June 2022

Section

Letter to the Editor

License

Copyright (c) 2022 Pakistan Journal of Medicine and Dentistry

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.